*Mayo Clinic Rochester, Rochester, MN
†Mayo Clinic Arizona, Scottsdale, AZ
‡Mayo Clinic Florida, Jacksonville, FL
§Wichita CCOP, Wichita KS
∥Hematology and Oncology of Dayton, Dayton, OH
¶Lehigh Valley Hospital, Allentown, PA
Additional participating institutions include: Carle Cancer Center CCOP, Urbana, IL 61801 (Kendrith Rowland, M.D.); CentraCare Clinic, St Cloud, MN 56301 (Donald J. Jurgens, M.D.); Metro-Minnesota Community Clinical Oncology Program, St Louis Park, MN 55416 (Patrick J. Flynn, M.D.); Abbott Northwestern Hospital, Minneapolis, MN 55407 (Daniel M. Anderson, M.D.); Rapid City Regional Oncology Group, Rapid City, SD 57709 (Richard C. Tenglin, M.D.); St Vincent Regional Cancer Center CCOP, Green Bay, WI 54303 (Anthony J. Jaslowski, M.D.)
Reprints: Steven Robert Alberts, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. e-mail: [email protected].
This study was conducted as a trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35195, CA-35090, CA-35267, and CA-35431 from the National Cancer Institute Department of Health and Human Services. The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institute of Health.
The authors declare no conflicts of interest.
